Cardiorespiratory fitness and risk of incident atrial fibrillation results from the henry ford exercise testing (FIT) project

Circulation

Volumn 131, Issue 21, 2015, Pages 1827-1834

  Qureshi, Waqas T ^a,b   Alirhayim, Zaid ^a,c   Blaha, Michael J ^d   Juraschek, Stephen P ^d   Keteyian, Steven J ^a   Brawner, Clinton A ^a   Al Mallah, Mouaz H ^a,e  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e KING ABDULLAH INTERNATIONAL MEDICAL RESEARCH CENTER   (Saudi Arabia)

Author keywords

Atrial fibrillation; Exercise; Prevention and control

Indexed keywords

ADULT; ARTICLE; ATRIAL FIBRILLATION; BLOOD PRESSURE; CARDIOPULMONARY EXERCISE TEST; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; FEMALE; FOLLOW UP; HENRY FORD EXERCISE TESTING; HUMAN; ICD-9; MAJOR CLINICAL STUDY; MALE; METABOLIC EQUIVALENT; OBESITY; PRIORITY JOURNAL; RESTING HEART RATE; TERTIARY CARE CENTER; TREADMILL EXERCISE; AGED; ATRIAL FLUTTER; BODY MASS; CHRONIC DISEASE; CLINICAL TRIAL; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIAS; ETHNIC GROUP; EXERCISE TEST; FITNESS; GENETICS; HYPERTENSION; INCIDENCE; LUNG DISEASES; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK; RISK FACTOR; THYROID DISEASES; UNITED STATES;

ADULT; AGED; ATRIAL FIBRILLATION; ATRIAL FLUTTER; BODY MASS INDEX; CHRONIC DISEASE; COMORBIDITY; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIAS; ETHNIC GROUPS; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; LUNG DISEASES; MALE; MICHIGAN; MIDDLE AGED; OBESITY; PHYSICAL FITNESS; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; THYROID DISEASES;

EID: 84935446743     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.014833     Document Type: Article

References (37)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
2. Gersh BJ, Tsang TS, Seward JB. The changing epidemiology and natural history of nonvalvular atrial fibrillation: clinical implications. Trans Am Clin Climatol Assoc. 2004;115:149-159.
3. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna W P, Seward JB, Tsang TS. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119-125. doi: 10.1161/CIRCULATIONAHA.105.595140.
4. Kim MH, Johnston SS, Chu BC, Dalal MR, Schulman KL. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes. 2011;4:313-320. doi: 10.1161/CIRCOUTCOMES.110.958165.
5. Bouzas-Mosquera A, Broullón FJ, Álvarez-García N, Méndez E, Peteiro J, Gándara-Sambade T, Prada O, Mosquera VX, Castro-Beiras A. Left atrial size and risk for all-cause mortality and ischemic stroke. CMAJ. 2011;183:E657-E664. doi: 10.1503/cmaj.091688.
6. Mont L, Tamborero D, Elosua R, Molina I, Coll-Vinent B, Sitges M, Vidal B, Scalise A, Tejeira A, Berruezo A, Brugada J; GIRAFA (Grup Integrat de Recerca en Fibril-lació Auricular) Investigators. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace. 2008;10:15-20. doi: 10.1093/europace/eum263.
7. Molina L, Mont L, Marrugat J, Berruezo A, Brugada J, Bruguera J, Rebato C, Elosua R. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace. 2008;10:618-623. doi: 10.1093/europace/eun071.
8. Al-Mallah MH, Keteyian SJ, Brawner CA, Whelton S, Blaha MJ. Rationale and design of the Henry Ford Exercise Testing Project (the FIT project). Clin Cardiol. 2014;37:456-461. doi: 10.1002/clc.22302.
9. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J. 1973;85:546-562.
10. Manolio TA, Burke GL, Savage PJ, Sidney S, Gardin JM, Oberman A. Exercise blood pressure response and 5-year risk of elevated blood pressure in a cohort of young adults: the CARDIA study. Am J Hypertens. 1994;7:234-241.
11. Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R, Dublin S. Identifying atrial fibrillation from electronic medical data: a systematic review. Pharmacoepidemiol Drug Saf. 2012;21:141-147.
12. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics. 1978;34:541-554.
13. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stats. 1988:1141-1154.
14. O'Keefe JH, Patil HR, Lavie CJ, Magalski A, Vogel RA, McCullough PA. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc. 2012;87:587-595. doi: 10.1016/j.mayocp.2012.04.005.
15. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995;6:356-365.
16. Marrie RA, Dawson NV, Garland A. Quantile regression and restricted cubic splines are useful for exploring relationships between continuous variables. J Clin Epidemiol. 2009;62:511-7.e1. doi: 10.1016/j.jclinepi.2008.05.015.
17. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant. 2007;40:381-387. doi: 10.1038/sj.bmt.1705727.
18. Bouchard C, Daw EW, Rice T, Pérusse L, Gagnon J, Province MA, Leon AS, Rao DC, Skinner JS, Wilmore JH. Familial resemblance for VO2max in the sedentary state: the HERITAGE family study. Med Sci Sports Exerc. 1998;30:252-258.
19. Huxley RR, Misialek JR, Agarwal SK, Loehr LR, Soliman EZ, Chen LY, Alonso A. Physical activity, obesity, weight change, and risk of atrial fibrillation: the Atherosclerosis Risk in Communities study. Circ Arrhythm Electrophysiol. 2014;7:620-625. doi: 10.1161/CIRCEP.113.001244.
20. Everett BM, Conen D, Buring JE, Moorthy MV, Lee IM, Albert CM. Physical activity and the risk of incident atrial fibrillation in women. Circ Cardiovasc Qual Outcomes. 2011;4:321-327. doi: 10.1161/CIRCOUTCOMES.110.951442.
21. Azarbal F, Stefanick ML, Salmoirago-Blotcher E, Manson JE, Albert CM, LaMonte MJ, Larson JC, Li W, Martin LW, Nassir R, Garcia L, Assimes TL, Tharp KM, Hlatky MA, Perez MV. Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. J Am Heart Assoc. 2014;3:. doi: 10.1161/JAHA.114.001127.
22. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292:2471-2477. doi: 10.1001/jama.292.20.2471.
23. Qureshi W, Soliman EZ, Solomon SD, Alonso A, Arking DE, Shah A, Gupta DK, Wagenknecht LE, Herrington D. Risk factors for atrial fibrillation in patients with normal versus dilated left atrium (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2014;114:1368-1372. doi: 10.1016/j.amjcard.2014.07.073.
24. Walters TE, Lee G, Spence S, Larobina M, Atkinson V, Antippa P, Goldblatt J, O'Keefe M, Sanders P, Kistler PM, Kalman JM. Acute atrial stretch results in conduction slowing and complex signals at the pulmonary vein to left atrial junction: insights into the mechanism of pulmonary vein arrhythmogenesis. Circ Arrhythm Electrophysiol. 2014;7:1189-1197. doi: 10.1161/CIRCEP.114.001894.
25. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J. 2001;22:1852-1923.
26. Qaddoura A, Kabali C, Drew D, van Oosten EM, Michael KA, Redfearn DP, Simpson CS, Baranchuk A. Obstructive sleep apnea as a predictor of atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis. Can J Cardiol. 2014;30:1516-1522. doi: 10.1016/j.cjca.2014.10.014.
27. Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res. 2005;97:629-636. doi: 10.1161/01.RES.0000183735.09871.61.
28. Wallentin L, Hijazi Z, Andersson U, Alexander JH, De Caterina R, Hanna M, Horowitz JD, Hylek EM, Lopes RD, Asberg S, Granger CB, Siegbahn A. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation. 2014;130:1847-1858.
29. Nigam A, Talajic M, Roy D, Nattel S, Lambert J, Nozza A, Jones P, Ramprasath VR, O'Hara G, Kopecky S, Brophy JM, Tardif JC; AFFORD Investigators. Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress. J Am Coll Cardiol. 2014;64:1441-1448. doi: 10.1016/j.jacc.2014.07.956.
30. Galassetti P. Inflammation and oxidative stress in obesity, metabolic syndrome, and diabetes. Exp Diabetes Res. 2012;2012:943706. doi: 10.1155/2012/943706.
31. Suzuki K, Ito Y, Ochiai J, Kusuhara Y, Hashimoto S, Tokudome S, Kojima M, Wakai K, Toyoshima H, Tamakoshi K, Watanabe Y, Hayakawa N, Maruta M, Watanabe M, Kato K, Ohta Y, Tamakoshi A; JACC Study Group. Relationship between obesity and serum markers of oxidative stress and inflammation in Japanese. Asian Pac J Cancer Prev. 2003;4:259-266.
32. Myrstad M, Nystad W, Graff-Iversen S, Thelle DS, Stigum H, Aarønæs M, Ranhoff AH. Effect of years of endurance exercise on risk of atrial fibrillation and atrial flutter. Am J Cardiol. 2014;114:1229-1233. doi: 10.1016/j.amjcard.2014.07.047.
33. Guasch E, Nattel S. CrossTalk proposal: prolonged intense exercise training does lead to myocardial damage. J Physiol. 2013;591(pt 20):4939-4941. doi: 10.1113/jphysiol.2013.257238.
34. Ofman P, Khawaja O, Rahilly-Tierney CR, Peralta A, Hoffmeister P, Reynolds MR, Gaziano JM, Djousse L. Regular physical activity and risk of atrial fibrillation: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2013;6:252-256. doi: 10.1161/CIRCEP.113.000147.
35. Mont L, Elosua R, Brugada J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace. 2009;11:11-17. doi: 10.1093/europace/eun289.
36. Wilhelm M, Nuoffer JM, Schmid JP, Wilhelm I, Saner H. Comparison of pro-atrial natriuretic peptide and atrial remodeling in marathon versus non-marathon runners. Am J Cardiol. 2012;109:1060-1065. doi: 10.1016/j.amjcard.2011.11.039.
37. Wilhelm M, Roten L, Tanner H, Wilhelm I, Schmid JP, Saner H. Atrial remodeling, autonomic tone, and lifetime training hours in nonelite athletes. Am J Cardiol. 2011;108:580-585. doi: 10.1016/j.amjcard.2011.03.086.